AVITA Medical (RCEL) Raw Materials (2018 - 2022)

AVITA Medical (RCEL) has 5 years of Raw Materials data on file, last reported at $1.1 million in Q4 2022.

• For the quarter ending Q4 2022, Raw Materials fell 7.45% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2022 stood at $1.1 million (down 7.45% YoY), and the FY2022 full-year result was $1.1 million, down 7.45% from the prior year.
• Raw Materials for Q4 2022 stood at $1.1 million, down from $1.2 million in the prior quarter.
• Across five years, Raw Materials topped out at $1.2 million in Q4 2021 and bottomed at $589691.6 in Q2 2018.
• The 5-year median for Raw Materials is $964500.0 (2020), against an average of $913402.2.
• The widest annual swing landed in 2020, when Raw Materials soared 55.57%; it then decreased 7.45% in 2022.
• A 5-year view of Raw Materials shows it stood at $589691.6 in 2018, then gained by 3.23% to $608721.6 in 2019, then surged by 55.57% to $947000.0 in 2020, then increased by 29.04% to $1.2 million in 2021, then retreated by 7.45% to $1.1 million in 2022.
• The last three Raw Materials figures came in at $1.1 million (Q4 2022), $1.2 million (Q4 2021), and $982000.0 (Q2 2021), per Business Quant data.

Peer Comparison